Hypersensitivity to the active substance or to any of the excipients listed. As Ninlaro is administered in combination with lenalidomide and dexamethasone, refer to the SmPC for these medicinal products for additional special warnings and precautions for use.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
